Institutional investors purchased a net $6.2 million shares of ALIM during the quarter ended December 2014 and now own 50.71% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEERFIELD MANAGEMENT CO. LP Bought 2.2 Million shares of Alimera Sciences Inc
LONGWOOD CAPITAL PARTNERS LLC Bought 1.1 Million shares of Alimera Sciences Inc
PURA VIDA INVESTMENTS LLC Bought 952.9 Thousand shares of Alimera Sciences Inc